Tissue specific targeting of DNA nanodevices in a multicellular living organism

  1. Kasturi Chakraborty
  2. Palapuravan Anees
  3. Sunaina Surana
  4. Simona Martin
  5. Jihad Aburas
  6. Sandrine Moutel
  7. Franck Perez
  8. Sandhya P Koushika
  9. Paschalis Kratsios  Is a corresponding author
  10. Yamuna Krishnan  Is a corresponding author
  1. University of Chicago, United States
  2. University College London, United Kingdom
  3. Institut Curie, France
  4. TATA Institute of Fundamental Research, India

Abstract

Nucleic acid nanodevices present great potential as agents for logic-based therapeutic intervention as well as in basic biology. Often, however, the disease targets that need corrective action are localized in specific organs and thus realizing the full potential of DNA nanodevices also requires ways to target them to specific cell-types in vivo. Here we show that by exploiting either endogenous or synthetic receptor-ligand interactions and by leveraging the biological barriers presented by the organism, we can target extraneously introduced DNA nanodevices to specific cell types in C. elegans, with sub-cellular precision. The amenability of DNA nanostructures to tissue-specific targeting in vivo significantly expands their utility in biomedical applications and discovery biology.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Kasturi Chakraborty

    Chemistry, University of Chicago, Chicago, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0635-9028
  2. Palapuravan Anees

    Chemistry, University of Chicago, Chicago, United States
    Competing interests
    No competing interests declared.
  3. Sunaina Surana

    Department of Neuromuscular Diseases, University College London, London, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7017-3105
  4. Simona Martin

    Chemistry, University of Chicago, Chicago, United States
    Competing interests
    No competing interests declared.
  5. Jihad Aburas

    Neurobiology, University of Chicago, Chicago, United States
    Competing interests
    No competing interests declared.
  6. Sandrine Moutel

    Institut Curie, Paris, France
    Competing interests
    No competing interests declared.
  7. Franck Perez

    Institut Curie, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9129-9401
  8. Sandhya P Koushika

    Biological Sciences, TATA Institute of Fundamental Research, Mumbai, India
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1742-7356
  9. Paschalis Kratsios

    Department of Neurobiology, University of Chicago, Chicago, United States
    For correspondence
    pkratsios@uchicago.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1363-9271
  10. Yamuna Krishnan

    Chemistry, University of Chicago, Chicago, United States
    For correspondence
    yamuna@uchicago.edu
    Competing interests
    Yamuna Krishnan, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5282-8852

Funding

Air Force Office of Scientific Research (FA9550-19-0003)

  • Yamuna Krishnan

National Institute of Neurological Disorders and Stroke (1R01NS112139-01A1)

  • Yamuna Krishnan

Ono Pharma Foundation

  • Yamuna Krishnan

Whitehall Foundation

  • Paschalis Kratsios

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Kang Shen, Howard Hughes Medical Institute, Stanford University, United States

Publication history

  1. Received: February 24, 2021
  2. Preprint posted: March 6, 2021 (view preprint)
  3. Accepted: July 26, 2021
  4. Accepted Manuscript published: July 28, 2021 (version 1)
  5. Version of Record published: August 12, 2021 (version 2)

Copyright

© 2021, Chakraborty et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,575
    Page views
  • 199
    Downloads
  • 4
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Kasturi Chakraborty
  2. Palapuravan Anees
  3. Sunaina Surana
  4. Simona Martin
  5. Jihad Aburas
  6. Sandrine Moutel
  7. Franck Perez
  8. Sandhya P Koushika
  9. Paschalis Kratsios
  10. Yamuna Krishnan
(2021)
Tissue specific targeting of DNA nanodevices in a multicellular living organism
eLife 10:e67830.
https://doi.org/10.7554/eLife.67830

Further reading

    1. Biochemistry and Chemical Biology
    Tiantian Wei et al.
    Research Article Updated

    The dual-specificity tyrosine phosphorylation-regulated kinase DYRK2 has emerged as a critical regulator of cellular processes. We took a chemical biology approach to gain further insights into its function. We developed C17, a potent small-molecule DYRK2 inhibitor, through multiple rounds of structure-based optimization guided by several co-crystallized structures. C17 displayed an effect on DYRK2 at a single-digit nanomolar IC50 and showed outstanding selectivity for the human kinome containing 467 other human kinases. Using C17 as a chemical probe, we further performed quantitative phosphoproteomic assays and identified several novel DYRK2 targets, including eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) and stromal interaction molecule 1 (STIM1). DYRK2 phosphorylated 4E-BP1 at multiple sites, and the combined treatment of C17 with AKT and MEK inhibitors showed synergistic 4E-BP1 phosphorylation suppression. The phosphorylation of STIM1 by DYRK2 substantially increased the interaction of STIM1 with the ORAI1 channel, and C17 impeded the store-operated calcium entry process. These studies collectively further expand our understanding of DYRK2 and provide a valuable tool to pinpoint its biological function.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Lukas P Feilen et al.
    Research Article

    Cleavage of membrane proteins in the lipid bilayer by intramembrane proteases is crucial for health and disease. Although different lipid environments can potently modulate their activity, how this is linked to their structural dynamics is unclear. Here we show that the carboxy-peptidase-like activity of the archaeal intramembrane protease PSH, a homolog of the Alzheimer's disease-associated presenilin/γ-secretase is impaired in micelles and promoted in a lipid bilayer. Comparative molecular dynamics simulations revealed that important elements for substrate binding such as transmembrane domain 6a of PSH are more labile in micelles and stabilized in the lipid bilayer. Moreover, consistent with an enhanced interaction of PSH with a transition-state analog inhibitor, the bilayer promoted the formation of the enzyme´s catalytic active site geometry. Our data indicate that the lipid environment of an intramembrane protease plays a critical role in structural stabilization and active site arrangement of the enzyme-substrate complex thereby promoting intramembrane proteolysis.